Nordson Corporation (BIT:1NDSN)

Aerovate Therapeutics Revenue

Nordson had revenue of $682.94M USD in the quarter ending April 30, 2025, with 4.96% growth. This brings the company's revenue in the last twelve months to $2.70B, up 1.98% year-over-year. In the fiscal year ending October 31, 2024, Nordson had annual revenue of $2.69B with 2.33% growth.

• Revenue (ttm): $2.70B
• Revenue Growth: +1.98%
• P/S Ratio: 4.48
• Revenue / Employee: $338.06K
• Employees: 8,000
• Market Cap: 10.69B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2024	2.69B	61.29M	2.33%
Oct 31, 2023	2.63B	38.35M	1.48%
Oct 31, 2022	2.59B	228.07M	9.65%
Oct 31, 2021	2.36B	241.11M	11.37%
Oct 31, 2020	2.12B	-73.13M	-3.33%